Harold O Koch, Jr

Title: Harold O Koch, Jr: Innovator in Depression Treatment

Introduction

Harold O Koch, Jr. is a notable inventor based in Mandeville, LA (US). He has made significant contributions to the field of mental health, particularly in the treatment of depression. With a total of 2 patents, his work focuses on innovative methods for selecting effective treatment regimens for individuals suffering from depression.

Latest Patents

Koch's latest patents include novel assays and methods for selecting treatment regimens for subjects with depression. These patents disclose systems and kits that identify nucleic acid polymorphisms, such as those at the MTHFR, MTR, or MTRR locus. Additionally, they involve determining expression levels of peripheral biomarkers, including SAM, SAH, 4-HNE, and hsCRP, from test samples of human subjects. These biomarkers are crucial for assessing the effectiveness of folate-containing compounds in treating depression, especially in cases of treatment-resistant depression. The methods also aim to improve the effectiveness of antidepressant drugs taken by subjects.

Career Highlights

Koch is associated with Nestec S.a., where he continues to develop innovative solutions for mental health treatment. His work has garnered attention for its potential to revolutionize how depression is treated, particularly through personalized medicine approaches.

Collaborations

Some of Koch's notable coworkers include George Papakostas and David Paul Kronlage. Their collaborative efforts contribute to advancing research and development in the field of depression treatment.

Conclusion

Harold O Koch, Jr. stands out as an influential inventor in the realm of mental health, with his patents paving the way for more effective treatment options for depression. His innovative approaches highlight the importance of personalized medicine in addressing complex health issues.